A novel nomogram model for predicting prognosis of non–small cell lung cancer with malignant pleural effusion
Oncology and Translational Medicine · 2026-08 · 12 (4) · 213-220
DOI: 10.1097/ot9.0000000000000084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology and Translational Medicine, online erschienen am 20.03.2025. Verfasst von Suning Li und 3 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The patients of non–small cell lung cancer (NSCLC) with malignant pleural effusion (MPE) typically had poor prognosis. It was still challenging to predict overall survival (OS) and make reasonable clinical treatment.
Methods
Patients diagnosed with NSCLC and MPE between January 2018 and January 2023 at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, were retrospectively identified. The cohort was randomly divided into the training and validation groups. Propensity score matching was performed, followed by COX regression analysis based on the matched patients. A nomogram was constructed based on the multivariate COX regression results. The performance of the nomogram was evaluated using calibration and concordance indices, as well as receiver operating characteristic curves.
Results
A total of 306 patients were included in this study. The median OS for the entire cohort was 233 days (95% confidence interval, 168.68–297.33), which improved to 242 days (95% confidence interval, 158.28–325.72) post–propensity score matching. Independent risk factors affecting OS included a history of respiratory system diseases, leukocyte count, neutrophil-to-lymphocyte ratio, serum albumin level, and targeted therapy. A nomogram predicting OS was developed based on the COX multivariate regression analysis. The concordance indices for these nomograms were 0.732 and 0.747 for the training and validation cohorts, respectively. Calibration curves demonstrated a good alignment between the predicted and actual survival probabilities at various time points in both cohorts.
Conclusions
The nomogram was successfully constructed to predict OS at 6 months, 1 year, and 2 years for NSCLC patients with MPE. This nomogram can potentially aid in clinical decision-making regarding the benefits of targeted therapy in this patient population.
Zitieren
APA
Li, S., Ding, D., Wang, M., & Cao, Y. (2026). A novel nomogram model for predicting prognosis of non–small cell lung cancer with malignant pleural effusion. Oncology and Translational Medicine, 12(4), 213-220. https://doi.org/10.1097/ot9.0000000000000084
Vancouver
Li S, Ding D, Wang M, Cao Y. A novel nomogram model for predicting prognosis of non–small cell lung cancer with malignant pleural effusion. Oncology and Translational Medicine. 2026;12(4):213-220. doi:10.1097/ot9.0000000000000084
BibTeX
@article{Li2026,
author = {Li, Suning and Ding, Dan and Wang, Meijia and Cao, Yong},
title = {A novel nomogram model for predicting prognosis of non–small cell lung cancer with malignant pleural effusion},
journal = {Oncology and Translational Medicine},
year = {2026},
volume = {12},
number = {4},
pages = {213--220},
doi = {10.1097/ot9.0000000000000084}
}
EUVIMED